Drug Profile

Naproxen sodium/metoclopramide - POZEN

Alternative Names: Metoclopramide/naproxen-sodium; MT 100; Naproxen-sodium/metoclopramide

Latest Information Update: 24 Dec 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator POZEN
Class Aminobenzoic acids; Antiemetics; Antimigraines; Antipyretics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Phenyl ethers; Small molecules
Mechanism of Action Cyclooxygenase inhibitors; Dopamine receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Registered Migraine

Most Recent Events

24 Dec 2024 Chemical structure information added.
28 Nov 2005 Registered for Migraine in United Kingdom (PO)
05 Aug 2005 Withdrawn - Preregistration for Migraine in USA (PO)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com